Annual report pursuant to Section 13 and 15(d)

Inventory

v3.10.0.1
Inventory
12 Months Ended
Nov. 30, 2018
Inventory Disclosure [Abstract]  
Inventory

Note 3 – Inventory

Inventory is comprised of public cord blood banking specimens, collection kits, finished goods, work-in-process and raw materials. Collection kits are used in the collection and processing of umbilical cord blood and cord tissue stem cells, finished goods include products purchased or assumed for resale and for the use in the Company’s processing and storage service. Inventory in the Public Cord Blood Bank includes finished goods that are specimens that are available for resale. The Company considers inventory in the Public Cord Blood Bank that has not completed all testing to determine viability to be work in process. The components of inventory at November 30, 2018 and November 30, 2017 are as follows:

 

     As of November 30, 2018      As of November 30, 2017  

Raw materials

   $ —        $ —    

Work-in-process

     188,085        97,210  

Work-in-process – Public Bank

     —          —    

Finished goods

     5,262        210,854  

Finished goods – Public Bank

     15,831,081        —    

Collection kits

     19,163        14,220  

Inventory reserve

     (7,718      (7,718
  

 

 

    

 

 

 

Total inventory

   $ 16,035,873      $ 314,566